AU2003252459A1 - A platform for transdermal formulations (ptf) - Google Patents

A platform for transdermal formulations (ptf) Download PDF

Info

Publication number
AU2003252459A1
AU2003252459A1 AU2003252459A AU2003252459A AU2003252459A1 AU 2003252459 A1 AU2003252459 A1 AU 2003252459A1 AU 2003252459 A AU2003252459 A AU 2003252459A AU 2003252459 A AU2003252459 A AU 2003252459A AU 2003252459 A1 AU2003252459 A1 AU 2003252459A1
Authority
AU
Australia
Prior art keywords
composition according
patch
ptf
oily emulsion
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003252459A
Other languages
English (en)
Inventor
Yuval Simha Landschaft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOLDEN DEVELOPMENT Ltd
Original Assignee
HOLDEN DEV Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOLDEN DEV Ltd filed Critical HOLDEN DEV Ltd
Publication of AU2003252459A1 publication Critical patent/AU2003252459A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003252459A 2002-06-27 2003-06-21 A platform for transdermal formulations (ptf) Abandoned AU2003252459A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10228680.9 2002-06-27
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)
PCT/IB2003/003467 WO2004002444A2 (en) 2002-06-27 2003-06-21 A platform for transdermal formulations (ptf)

Publications (1)

Publication Number Publication Date
AU2003252459A1 true AU2003252459A1 (en) 2004-01-19

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003252459A Abandoned AU2003252459A1 (en) 2002-06-27 2003-06-21 A platform for transdermal formulations (ptf)

Country Status (14)

Country Link
US (1) US20050118241A1 (cg-RX-API-DMAC7.html)
EP (1) EP1515706A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005535635A (cg-RX-API-DMAC7.html)
KR (1) KR20050027995A (cg-RX-API-DMAC7.html)
CN (1) CN1665492A (cg-RX-API-DMAC7.html)
AR (1) AR040287A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003252459A1 (cg-RX-API-DMAC7.html)
CA (1) CA2490022A1 (cg-RX-API-DMAC7.html)
DE (1) DE10228680A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012732A (cg-RX-API-DMAC7.html)
MY (1) MY157852A (cg-RX-API-DMAC7.html)
TW (1) TW200500093A (cg-RX-API-DMAC7.html)
WO (1) WO2004002444A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200500710B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20120283332A1 (en) * 2009-05-12 2012-11-08 Ohio University Transdermal delivery of metformin
US10363229B2 (en) 2009-06-05 2019-07-30 Joan McInyre Caron Methods and compositions for the treatment of cancer
RU2659729C2 (ru) * 2012-07-30 2018-07-03 Матинас Биофарма Нанотекнолоджис, Инк. Кохлеаты, полученные с использованием фосфатидилсерина сои

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
DE69216836T2 (de) * 1991-07-26 1997-06-12 Smithkline Beecham Corp W/o mikroemulsionen
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
WO1996010439A1 (en) * 1994-09-30 1996-04-11 Kabushiki Kaisya Advance Interface for iontophoretic percutaneous administration, and agent and method for treating the skin for that purpose
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
JP2002519366A (ja) * 1998-07-07 2002-07-02 トランスダーマル・テクノロジーズ・インコーポレーテツド 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達
CA2369594A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Also Published As

Publication number Publication date
WO2004002444A2 (en) 2004-01-08
CN1665492A (zh) 2005-09-07
TW200500093A (en) 2005-01-01
WO2004002444A3 (en) 2004-03-11
ZA200500710B (en) 2005-09-05
AR040287A1 (es) 2005-03-23
US20050118241A1 (en) 2005-06-02
MY157852A (en) 2016-07-29
CA2490022A1 (en) 2004-01-08
JP2005535635A (ja) 2005-11-24
MXPA04012732A (es) 2005-11-17
EP1515706A2 (en) 2005-03-23
DE10228680A1 (de) 2004-01-22
KR20050027995A (ko) 2005-03-21

Similar Documents

Publication Publication Date Title
US6274166B1 (en) Transdermal delivery system
AU2003238862B9 (en) Formulations for amylin agonist peptides
TWI685348B (zh) 速效胰島素組合物
US7033998B2 (en) Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
NZ263891A (en) Pharmaceutical composition of progesterone and/or 17-beta-estradiol, the active ingredient(s) being dissolved in an oil that is the inner phase of an oil-water two-phase system
US20050118241A1 (en) Platform for transdermal formulations (ptf)
RU2543635C2 (ru) Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости
Fransson et al. Transdermal absorption of a liposomeencapsulated formulation of lidocaine following topical administration in cats
SK9062000A3 (en) Transmucosal formulations of levosimendan
US7291591B2 (en) Alcohol-free transdermal insulin composition
EP1079801A1 (en) A pharmaceutical formulation for nasal administration
US6667052B2 (en) Transdermal delivery system
KR100466757B1 (ko) 생체에 펩티드성 약물을 유입시키기 위한 국소 제제
JP2002536337A (ja) 麻酔の調節
Zimmer et al. Noninvasive drug delivery
JPS6045161B2 (ja) 熱傷の治療剤
JPH01501708A (ja) アミノ酸の経鼻投与
JPH0761942B2 (ja) 血中尿酸濃度の低下用医薬
JPS6237017B2 (cg-RX-API-DMAC7.html)
KR930002093B1 (ko) 단백질 의약품의 경구투여용 조성물
JPH06154287A (ja) 治療装置
Higgins Insulin delivery: will injections always be necessary?
TAMAKI et al. Intestinal Absorption of a New Anticholinergic Agent, Timepidium Bromide. II. Enhancement of Absorption
JPH03128327A (ja) モチリン製剤

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application